The clinical study of the effect of Jamyang.Jaum prescriptions on the hypertension evolution in cerebral hemorrhage patients

잠양자음약물(潛陽滋陰藥物)이 뇌출혈(腦出血) 환자(患者)의 고혈압(高血壓)에 미치는 영향(影響)에 대한 임상적(臨床的) 고찰(考察)

  • Choi, Cheol-Won (Dept. Internal Medicine, College of Medicine, Won-Kwang University) ;
  • Kim, Dong-Woung (Dept. Internal Medicine, College of Medicine, Won-Kwang University) ;
  • Shin, Sun-Ho (Dept. Internal Medicine, College of Medicine, Won-Kwang University) ;
  • Jeon, Heui-Jun (Dept. Internal Medicine, College of Medicine, Won-Kwang University) ;
  • Hwang, Bo-Youn (Dept. Internal Medicine, College of Medicine, Won-Kwang University) ;
  • Jeong, Dae-Young (Dept. Internal Medicine, College of Medicine, Won-Kwang University)
  • 최철원 (원광대학교 부속 전주한방병원 심계내과학교실) ;
  • 김동웅 (원광대학교 부속 전주한방병원 심계내과학교실) ;
  • 신선호 (원광대학교 부속 전주한방병원 심계내과학교실) ;
  • 전희준 (원광대학교 부속 전주한방병원 심계내과학교실) ;
  • 황보연 (원광대학교 부속 전주한방병원 심계내과학교실) ;
  • 정대영 (원광대학교 부속 전주한방병원 심계내과학교실)
  • Published : 1997.04.30

Abstract

The causes of stroke are presumed hypertension, atherosclerosis,. cardiac disease, diabetes mellitus and old age and risk factors of stroke are suggested hypertension, hyperlipidemia. obesity, smoking and drinking etc. Especilly, hypertension is one of the most important cause and risk factor of stroke, therfore without therapy hypertension leads to stroke. The frequence of hypertension is significantly higher in hemorrhage patients of intracranial hemorrhage and subarachnoid hemorrhage. Antihypertensive therapy has an impact not only on the primary prevention of stroke but also on stroke recurrence and the declining of stroke motality has been attributed to the widespread availability and use of antihypertensive therapy. The goals of antihypertensive therapy decrease the complications and motalitv of cardiovascular system and prevent the promoting arteriosclerosis. In this study, we observed the blood pressure change of cb-hemorrhagic patients with hypertension who were hospitalized from 1996. 3. 1 to 1997. 2 .26 in Wonkwang Oriental Hospital. These patients had no antihypertensive therapy and were supplied herb med(Jaum sikpoongtang, Chungrijagamtang, Gojinumja) in medication. Our results suggested as follows. 1. Systolic and diastolic average BP at admission is $150.71{\pm}15.61mmHg$ and $95.00{\pm}8.8mmHg$ and this is hypertension state defining WHO 2. During one week in admission, the blood pressure demostrated a marked declination by SBP 8.97mmHg and DBP 6.22mmHg. 3. During two week in admission, the declination of SBP was significant in paired t-test(p<0.05) but, the declination of DBP was non-significant in paired t-test. 4. The blood pressure during third and fourth weeks gradually declined but, non-significant in test. According to the above results, we suggested that the BP declination Was affected by $Jamyang{\cdot}Jaum$ prescriptions in acute stage of cerebral hemorrhage.

Keywords

References

  1. 中風學術大會論文集 中風 김영석
  2. 대한신경과학회지 v.6 no.1 뇌졸중의 위험인자에 관한 조사 신건민;이동국;이상도;서정규;박영춘
  3. Cecil, Arterial Hypertention J, claude Bennet;Fred plum
  4. 實用中醫內科學 黃文東
  5. Ann Neurol v.5 The decreasing incidence of primary intracerebral lemorrhage:a population study Furlan AJ;Whisnant JP;Elveback LR
  6. 약물요법$\cdot$고혈압 의학교육연수원
  7. 고혈압 대한의학협회 분과학회협의회
  8. JAMA v.246 Blood pressure after stroke Wallace JD;Levy LL
  9. Am J Med Sci. v.286 Lowering of blood pressure after stroke Loyke HF
  10. Stroke v.4 Impaired neurogenic cerebrovascular control and dysautoregulation after stroke Meyor JS;Shimazu K;Fukuuchi Y(et al.)
  11. Hypertesion and the brain Epidemiologic appasial of hypertesion and risk Wolf PA;Kannel WB;Verter J;Guthrie GP;Kotchen TA(eds.)
  12. Symposium on cebrovascular disease Current status of risk factors for stroke in neurology clinics Wolf PA;Kannel WB;Verter J;Barnet HlM(ed.)
  13. JAMA v.245 Systolic bllod pressure, arterial rigidity and risk factor of stroke:The Framingham Study Wolf PA;Kannel WB;MeGee DL(et al.)
  14. Neurology v.34 Subarachnoid and intracerebral hemorrhage:natural history, prognosis and precursive factors in the Framingham Study Sacco RL;Wolf PA;Bharucha NE
  15. Stroke v.17 Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage:a population-based case-control study Bonita R
  16. 心腦血管病中醫證治學$\cdot$腦出血 越鴻斌;王雨亭
  17. J Cereb Blood Flow Metab v.3 no.SUP.1 Lower limit of blood pressure in treatment of acute hypertensive intracranial hemorrhage (AHCH) Kneko T;Swada T;Niirni T.
  18. Curr Probl Cardiol v.7 Hypertension associated with intracerebral hemorrhage Ram CVS
  19. M Sinai J Med v.40 Treatment of ruptured intracranial aneurysm by induced hypotention Slosberg PS
  20. 高血壓 全國韓醫科大學 心系內科學敎室
  21. 臨床內科學 辛民敎
  22. 中藥藥理와 應用 王浴生
  23. 대한신경과학회지 v.7 no.1 재발된 뇌졸중에 관한 임상적 고찰 정원영;손영호;이영진;이성수;이명식;최일생(외)
  24. 성인병$\cdot$노인병 서수규
  25. Clinical Neurology$\cdot$Hemorrhagic Intracranial Vascular disease Harold P;Adams Jr;Jose Biller
  26. Aneurysmal subarachnoid hemorrhage:report of cooperative study Antihypertensive and antifibrinolytic therapy following subarachnoid hemorrhage from ruptured intracranial aneurysm Nibbelink DW;Sacks AL;Nibbelink DW;Torner JC(eds.)
  27. Stroke v.4 Report of the Joint Committe for Stroke Facilities VII. Medical and surgical management of stroke American Heart Association
  28. Intracerebal Hematmas$\cdot$Hypertention and the brain Theodore A. Kotchen;Kemin A
  29. 강압제의 선택 이방헌